Literature DB >> 168999

Pathology of osteosarcoma.

D C Dahlin.   

Abstract

Osteosarcoma of bone is a tumor composed of malignant cells that produce osteoid. Some tumors show predominant chondroid or fibromatoid ground substance. All, however, are highly malignant and about 80 per cent produce death with metastases. The roentgenogram affords important evidence for the correct diagnosis of many of them. Differential diagnosis should include consideration of those sarcomas with many benign giant cells and the group of "telangiectatic" osteosarcomas that may contain only small diagnostic areas. Malignant fibrous histiocytoma is now considered as a possible diagnosis for some malignant bone tumors, but the exact criteria for the diagnosis of this condition are still somewhat obscure. Newer modalities of adjunctive treatment, such as resection of pulmonary metastases, chemotherapy, and immunotherapy, give promise of improving the prognosis for osteosarcoma.

Entities:  

Mesh:

Year:  1975        PMID: 168999     DOI: 10.1097/00003086-197509000-00004

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  11 in total

1.  THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.

Authors:  B E Engel; W D Cress; P G Santiago-Cardona
Journal:  Cell Health Cytoskelet       Date:  2014-12-18

2.  Epithelioid osteoblastoma: A histopathological dilemma between juvenile ossifying fibroma and low-grade osteosarcoma.

Authors:  Sudeendra Prabhu; Soniya Adyanthaya; Maji Jose; B H Sripathi Rao
Journal:  J Oral Maxillofac Pathol       Date:  2017 Jan-Apr

Review 3.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

4.  Osteosarcoma following a fractured shaft of femur. A case report.

Authors:  P T Rao; N K Pradhan; S Acharya
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

5.  The submicroscopic structure of a chondroblastic osteogenic sarcoma.

Authors:  V Horn; D Spohrová; Z Bozdĕch; M Janecek; A Roessner; J Bucek
Journal:  Arch Orthop Trauma Surg       Date:  1984

6.  Comparison of quantitative ground substance analysis in biopsy and resected tumour in osteosarcomas.

Authors:  W Kersjes; U Heise; K Winkler; G Delling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 7.  Low back pain in older adults: risk factors, management options and future directions.

Authors:  Arnold Yl Wong; Jaro Karppinen; Dino Samartzis
Journal:  Scoliosis Spinal Disord       Date:  2017-04-18

8.  miR-505 inhibits proliferation of osteosarcoma via HMGB1.

Authors:  Guangzhang Li; Fajing Liu; Jun Miao; Yongcheng Hu
Journal:  FEBS Open Bio       Date:  2020-05-31       Impact factor: 2.693

9.  An integrative multi-platform analysis for discovering biomarkers of osteosarcoma.

Authors:  Guodong Li; Wenjuan Zhang; Huazong Zeng; Lei Chen; Wenjing Wang; Jilong Liu; Zhiyu Zhang; Zhengdong Cai
Journal:  BMC Cancer       Date:  2009-05-16       Impact factor: 4.430

10.  The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts.

Authors:  Bernadette Sosa-García; Viviana Vázquez-Rivera; Jonathan N González-Flores; Brienne E Engel; W Douglas Cress; Pedro G Santiago-Cardona
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.